Table: Kobayashi Pharmaceutical - 9-MTH group results
Oct 27 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2020 Sep 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 105.05 111.20 154.00
(-5.5 pct) (-2.7 pct)
Operating 19.52 19.83 25.90
(-1.6 pct) (+0.9 pct)
Recurring 21.04 21.45 27.60
(-1.9 pct) (-0.9 pct)
Net 15.26 15.25 19.20
(+0.1 pct) (+0.3 pct)
EPS 195.21 yen 194.20 yen 245.64 yen
Ann Div 73.00 yen 75.00 yen
-Q2 div 34.00 yen 33.00 yen
-Q4 div 40.00 yen 41.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows